Provided by Tiger Trade Technology Pte. Ltd.

Passage Bio, Inc.

4.51
+0.07001.58%
Post-market: 4.510.00000.00%16:10 EDT
Volume:39.26K
Turnover:171.28K
Market Cap:14.47M
PE:-0.40
High:4.66
Open:4.37
Low:4.30
Close:4.44
52wk High:20.00
52wk Low:3.29
Shares:3.21M
Float Shares:3.20M
Volume Ratio:1.95
T/O Rate:1.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-11.3124
EPS(LYR):-14.3500
ROE:-169.09%
ROA:-45.62%
PB:3.25
PE(LYR):-0.31

Loading ...

Analysts Conflicted on These Healthcare Names: Passage Bio (PASG) and Omnicell (OMCL)

TIPRANKS
·
Apr 21

BUZZ-U.S. STOCKS ON THE MOVE-Adobe, Agios, QXO

Reuters
·
Apr 20

BUZZ-U.S. STOCKS ON THE MOVE-TopBuild, MDA Space, Biogen

Reuters
·
Apr 20

Passage Bio Starts Strategic Review After FDA Doesn't Support Single-Arm Trial

Dow Jones
·
Apr 20

BUZZ-Passage Bio rises as early‑stage data for rare dementia gene therapy shows promise

Reuters
·
Apr 20

Passage Bio posts updated interim data from Phase 1/2 upliFT-D trial of PBFT02

Reuters
·
Apr 20

Passage Bio Inc - Pbft02-Treated Patients With Cdr 1 Show 54% Reduction in Frontotemporal Cortex Atrophy at 12 Months

THOMSON REUTERS
·
Apr 20

Passage Bio Inc - Pbft02-Treated Patients With Cdr 1 Show 64% Reduction in Whole Brain Atrophy at 12 Months

THOMSON REUTERS
·
Apr 20

Passage Bio: Also Announced Has Engaged Wedbush Pacgrow as Financial Advisor, Has Initiated Review of Strategic Alternatives

THOMSON REUTERS
·
Apr 20

Passage Bio Inc - Pbft02 Generally Well-Tolerated With No New Treatment-Related Serious Adverse Events Reported

THOMSON REUTERS
·
Apr 20

Passage Bio announces annual shareholder meeting via virtual webcast

Reuters
·
Apr 07

Passage Bio Inc : Oppenheimer Initiates Coverage With Outperform Rating; Target Price $30

THOMSON REUTERS
·
Mar 31

Top Premarket Gainers

MT Newswires Live
·
Mar 19

Passage Bio Ends Hopewell Lab Lease, Extends Cash Runway

TIPRANKS
·
Mar 10

Passage Bio Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Mar 05

Passage Bio (PASG) Gets a Buy from Chardan Capital

TIPRANKS
·
Mar 04

Passage Bio Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Mar 03

Passage Bio Q4 EPS $(4.09) Misses $(2.68) Estimate

Benzinga Earnings
·
Mar 03

Passage Bio's 2025 net loss narrows

Reuters
·
Mar 03

Passage Bio FY 2025 net loss totals USD 45.5 million -29.7%

Reuters
·
Mar 03